Blog

Stem Cell Therapeutics Announces Resignation of Director – MarketWatch

Stem Cell Therapeutics Announces Resignation of Director
MarketWatch
“The mandate given to me to rebuild and re-establish Stem Cell Therapeutics as a viable company with a promising future was accomplished with the establishment of a board of exceptional recognition, the acquisition of Trillium Therapeutics in April

…read more    

2014-01-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.